Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?

British Journal of Nutrition

Volumn 114, Issue 11, 2015, Pages 1756-1765

  Gomes, J M G ^a   Costa, J A ^b   Alfenas, R C ^b  

^a Campus Rio Pomba   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Calcium; Endotoxin; Gut microbiota; Intestinal permeability; Lipopolysaccharide

Indexed keywords

BILE ACID; CALCIUM; CALCIUM PHOSPHATE; CLAUDIN; ENDOTOXIN; FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; LACTIC ACID; OCCLUDIN; PLACEBO; PROBIOTIC AGENT; PROTEIN ZO1; TIGHT JUNCTION PROTEIN; CALCIUM INTAKE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM; CALCIUM ABSORPTION; CLOSTRIDIUM; COLON; COMBINATION CHEMOTHERAPY; CYTOTOXICITY; DIABETES MELLITUS; DIET SUPPLEMENTATION; ENDOTOXEMIA; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; FECES ANALYSIS; FERMENTATION; GENE; GENE EXPRESSION; GUT BARRIER DISINTEGRATION; HORMONE RELEASE; HUMAN; INTESTINAL INTEGRITY; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LUMINAL CYTOTOXICITY; MONOTHERAPY; NERVE FUNCTION; NONHUMAN; OBESITY; PH; PRECIPITATION; SALMONELLA; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; STOMACH ACID SECRETION; STOMACH PH; SYSTEMATIC REVIEW; TIGHT JUNCTION GENE; ANIMAL; BIOLOGICAL MODEL; CALCIUM INTAKE; DEFICIENCY; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; GASTROENTERITIS; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MILK; NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; PERMEABILITY; THERAPEUTIC USE;

ANIMALS; CALCIUM; CALCIUM, DIETARY; DEFICIENCY DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; MILK; MODELS, BIOLOGICAL; OBESITY; PERMEABILITY;

EID: 84949318659     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515003608     Document Type: Article

References (96)

1. Miller GD, Jarvis JK & McBean LD (2001) The importance of meeting calcium needs with foods. J Am Coll Nutr 20, 168S-185S.
2. Ferreira TS, Torres MRS & Sanjuliani AF (2013) Dietary calcium intake is associated with adiposity, metabolic profile, inflammatory state and blood pressure, but not with erythrocyte intracellular calcium and endothelial function in healthy pre-menopausal women. Br J Nutr 110, 1079-1088.
3. Pittas AG, Lau J, Hu FB, et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 92, 2017-2029.
4. Zemel MB, Shi H, Greer B, et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132-1138.
5. Jacobsen R, Lorenzen J, Toubro S, et al. (2005) Effect of shortterm high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes 29, 292-301.
6. Youn JH, Gulve EA & Holloszy JO (1991) Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Cell Physiol 260, C555-C561.
7. Gilon P, Chae HY, Rutter GA, et al. (2014) Calcium signaling in pancreatic β-cells in health and in type 2 diabetes. Cell Calcium 56, 340-361.
8. Trautvetter U & Jahreis G (2014) Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human study. Br J Nutr 111, 287-293.
9. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
10. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
11. Larsen N, Vogensen FK, van den Berg FW, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085.
12. Wu X, Ma C, Han L, et al. (2010) Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 61, 69-78.
13. Frazier TH, DiBaise JK & McClain CJ (2011) Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr 35, 14S-20S.
14. Moreno-Indias I, Cardona F, Tinahones FJ, et al. (2014) Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 5, 190.
15. Odenwald MA & Turner JR (2013) Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 11, 1075-1083.
16. Natividad JM & Verdu EF (2013) Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 69, 42-51.
17. Teixeira TFS, Moreira APB, Silva NCS, et al. (2014) Intestinal permeability measurements: general aspects and possible pitfalls. Nutr Hosp 29, 269-281.
18. Lopetuso LR, Scaldaferri F, Bruno G, et al. (2015) The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci 19, 1068-1076.
19. Musso G, Gambino R & Cassader M (2010) Obesity, diabetes, and gut microbiota: The hygiene hypothesis expanded? Diabetes Care 33, 2277-2284.
20. Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
21. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
22. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
23. Jayashree B, Bibin YS, Prabhu D, et al. (2014) Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 388, 203-210.
24. Imamura F, Micha R, Khatibzadeh S, et al. (2015) Dietary quality among men and women in 187 countries in 1990 and 2010: A systematic assessment. Lancet Glob Health 3, e132-e142.
25. David LA, Maurice CF, Carmody RN, et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563.
26. Bovee-Oudenhoven I, Termont D, Dekker R, et al. (1996) Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut 38, 59-65.
27. Bovee-Oudenhoven IM, Termont DS, Weerkamp AH, et al. (1997) Dietary calcium inhibits the intestinal colonization and translocation of Salmonella in rats. Gastroenterology 113, 550-557.
28. Kopic S & Geibel JP (2013) Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev 93, 189-268.
29. Álvarez-Ordóñez A, Begley M, Prieto M, et al. (2011) Salmonella spp. survival strategies within the host gastrointestinal tract. Microbiology 157, 3268-3281.
30. Sarker SA & Gyr K (1992) Non-immunological defence mechanisms of the gut. Gut 33, 987-993.
31. Zhu H, Hart CA & Sales D (2006) Bacterial killing in gastric juice-effect of pH and pepsin on Escherichia coli and Helicobacter pylori. J Med Microbiol 55, 1265-1270.
32. Berg RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4, 430-435.
33. Dicksved J, Lindberg M, Rosenquist M, et al. (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58, 509-516.
34. Mills S, Ross RP, Hill C, et al. (2011) Milk intelligence: mining milk for bioactive substances associated with human health. Int Dairy J 21, e401.
35. Venema K (2012) Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 22, 123-140.
36. Lapré JA, De Vries HT, Koeman JH, et al. (1993) The antiproliferative effect of dietary calcium on colonic epithelium is mediated by luminal surfactants and dependent on the type of dietary fat. Cancer Res 53, 784-789.
37. Govers MJ, Termont DS & Van der Meer R (1994) Mechanism of the antiproliferative effect of milk mineral and other calcium supplements on colonic epithelium. Cancer Res 54, 95-100.
38. Bovee-Oudenhoven IMJ, Wissink MLG, Wouters JTM, et al. (1999) Dietary calcium phosphate stimulates intestinal lactobacilli and decreases the severity of a Salmonella infection in rats. J Nutr 129, 607-612.
39. Van der Meer R, Welberg JWM, Kuipers F, et al. (1990) Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology 99, 1653-1659.
40. Govers MJ & Van der Meer R (1993) Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 34, 365-370.
41. Govers MJAP, Termont DSML, Lapré JA, et al. (1996) Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res 56, 3270-3275.
42. Ditscheid B, Keller S & Jahreis G (2009) Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences. Eur J Nutr 48, 22-30.
43. Trautvetter U, Ditscheid B, Kiehntopf M, et al. (2012) A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans. Clin Nutr 31, 230-237.
44. Zheng H, Yde CC, Clausen MR, et al. (2015) Metabolomics investigation to shed light on cheese as a possible piece in the French paradox puzzle. J Agric Food Chem 63, 2830-2839.
45. Begley M, Gahan CG & Hill C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29, 625-651.
46. Floch MH (2002) Bile salts, intestinal microbiota and enterohepatic circulation. Digest Liver Dis 34, S54e7.
47. Schepens MA, ten Bruggencate SJ, Schonewille AJ, et al. (2012) The protective effect of supplemental calcium on colonic permeability depends on a calcium phosphateinduced increase in luminal buffering capacity. Br J Nutr 107, 950-956.
48. Roberton AM (1993) Roles of endogenous substances and bacteria in colorectal cancer. Mutation Res 290, 71-78.
49. Lapré JA, Termont DS, Groen AK, et al. (1992) Lytic effects of mixed micelles of fatty acids and bile acids. Am J Physiol. 263, G333-G337.
50. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, et al. (2004) Dietary fructo-oligosaccharides and inulin decrease resistance of rats to Salmonella: protective role of calcium. Gut 53, 530-535.
51. Schepens MA, Schonewille AJ, Vink C, et al. (2009) Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. J Nutr 139, 1525-1533.
52. Van Ampting MT, Schonewille AJ, Vink C, et al. (2010) Damage to the intestinal epithelial barrier by antibiotic pretreatment of Salmonella-infected rats is lessened by dietary calcium or tannic acid. J Nutr 140, 2167-2172.
53. Ajouz H, Mukherji D & Shamseddine A (2014) Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol 12, 164.
54. Guarner F (2007) Studies with inulin-type fructans on intestinal infections, permeability, and inflammation. J Nutr 137, 2568S-2571S.
55. Christensen R, Lorenzen JK, Svith CR, et al. (2009) Effect of calcium from dairy and dietary supplements on faecal fat excretion: A meta-analysis of randomized controlled trials. Obes Rev 10, 475-486.
56. Ten Bruggencate SJ, Snel J, Schoterman MH, et al. (2011) Efficacy of various dietary calcium salts to improve intestinal resistance to Salmonella infection in rats. Br J Nutr 105, 489-495.
57. Metzler-Zebeli BU, Vahjen W, Baumgärtel T, et al. (2010) Ileal microbiota of growing pigs fed different dietary calcium phosphate levels and phytase content and subjected to ileal pectin infusion. J Anim Sci 88, 147-158.
58. Metzler-Zebeli BU, Zijlstra RT, Mosenthin R, et al. (2011) Dietary calcium phosphate content and oat β-glucan influence gastrointestinal microbiota, butyrate-producing bacteria and butyrate fermentation in weaned pigs. FEMS Microbiol Ecol 75, 402-413.
59. Metzler-Zebeli BU, Mann E, Schmitz-Esser S, et al. (2013) Changing dietary calcium-phosphorus level and cereal source selectively alters abundance of bacteria and metabolites in the upper gastrointestinal tracts of weaned pigs. Appl Environ Microbiol 79, 7264-7272.
60. Mann E, Schmitz-Esser S, Zebeli Q, et al. (2014) Mucosaassociated bacterial microbiome of the gastrointestinal tract of weaned pigs and dynamics linked to dietary calciumphosphorus. PLOS ONE 9, e86950.
61. Kim SW, Suda W, Kim S, et al. (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20, 241-253.
62. Louis P & Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294, 1-8.
63. Ottman N, Smidt H, de Vos WM, et al. (2012) The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2, 104.
64. Nicholson JK, Holmes E, Kinross J, et al. (2012) Host-gut microbiota metabolic interactions. Science 336, 1262-1267.
65. Ridaura VK, Faith JJ, Rey FE, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214.
66. Ley RE (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26, 5-11.
67. Schepens MA, Rijnierse A, Schonewille AJ, et al. (2010) Dietary calcium decreases but short-chain fructo-oligosaccharides increase colonic permeability in rats. Br J Nutr 104, 1780-1786.
68. Fooks LJ & Gibson GR (2002) Probiotics as modulators of the gut flora. Br J Nutr 88, S39-S49.
69. Bronner F (2009) Recent developments in intestinal calcium absorption. Nutr Rev 67, 109-113.
70. Overduin J, Schoterman MH, Calame W, et al. (2013) Dietary galacto-oligosaccharides and calcium: effects on energy intake, fat-pad weight and satiety-related, gastrointestinal hormones in rats. Br J Nutr 109, 1338-1348.
71. Whisner CM, Martin BR, Schoterman MH, et al. (2013) Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: A double-blind cross-over trial. Br J Nutr 110, 1292-1303.
72. Weaver CM, Martin BR, Nakatsu CH, et al. (2011) Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem 59, 6501-6510.
73. Van Langen MAC & Dieleman LA (2009) Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 15, 454-462.
74. Pryde SE, Duncan SH, Hold GL, et al. (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133-139.
75. Canani RB, Costanzo MD, Leone L, et al. (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17, 1519-1528.
76. Louis P, Scott KP, Duncan SH, et al. (2007) Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102, 1197-1208.
77. Duncan SH, Louis P & Flint HJ (2007) Cultivable bacterial diversity from the human colon. Lett Appl Microbiol 44, 343-350.
78. Schwiertz A, Taras D, Schafer K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195.
79. Musso G, Gambino R & Cassader M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62, 361-380.
80. Schepens MA, Vink C, Schonewille AJ, et al. (2011) Supplemental antioxidants do not ameliorate colitis development in HLA-B27 transgenic rats despite extremely low glutathione levels in colonic mucosa. Inflamm Bowel Dis 17, 2065-2075.
81. Rao JP (2009) Influence of dietary calcium content on intestinal permeability in rat. Indian J Med Res 129, 681-684.
82. Arrieta MC, Bistritz L & Meddings JB (2006) Alterations in intestinal permeability. Gut 55, 1512-1520.
83. Teixeira TFS, Souza NCS, Chiarello PG, et al. (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31, 735-740.
84. Vilela EG, Torres HOG, Ferrari MLA, et al. (2008) Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res 41, 1105e9.
85. Gonzalez-Mariscal L, Contreras RG, Bolivar JJ, et al. (1990) Role of calcium in tight junction formationbetween epithelial cells. Am J Physiol 259, C978-C986.
86. Gumbiner BM (1996) Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84, 345-357.
87. Farquhar MG & Palade GE (1963) Junctional complexes in various epithelia. J Cell Biol 17, 375-412.
88. Hwang I, Yang H, Kang HS, et al. (2013) Alteration of tight junction gene expression by calcium-and vitamin D-deficient diet in the duodenum of calbindin-null mice. Int J Mol Sci 14, 22997-23010.
89. McVey Neufeld KA, Perez-Burgos A, Mao YK, et al. (2015) The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin. Neurogastroenterol Motil 27, 12534.
90. Dong CX, Zhao W, Solomon C, et al. (2014) The intestinal epithelial insulin-like growth factor-1 receptor links glucagonlike peptide-2 action to gut barrier function. Endocrinology 155, 370-379.
91. Metzler-Zebeli BU, Mann E, Ertl R, et al. (2015) Dietary calcium concentration and cereals differentially affect mineral balance and tight junction proteins expression in jejunum of weaned pigs. Br J Nutr 113, 1019-1031.
92. Creely SJ, McTernan PG, Kusminski CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747.
93. Moreira AP, Texeira TF, Ferreira AB, et al. (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108, 801-809.
94. Mani V, Hollis JH & Gabler NK (2013) Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab 10, 6.
95. Teixeira TF, Collado MC, Ferreira CL, et al. (2012) Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32, 637-647.
96. Ulluwishewa D, Anderson RC, McNabb WC, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141, 769-776.